biospecimen__admin__batch_number	425.45.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	B71183E4-77DF-4AD5-9FA0-9FB866D754C6
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-AACN-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-AACN-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-AACN-01A
biospecimen__bio__biospecimen_barcode_bottom	0174191378
biospecimen__bio__day_of_creation	04
biospecimen__bio__day_of_shipment	28
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	04
biospecimen__bio__month_of_shipment	05
biospecimen__bio__pathology_report_file_name	TCGA-DD-AACN.449B3C67-3530-4728-9F38-F44F4D8EC027.pdf
biospecimen__bio__plate_column	3
biospecimen__bio__plate_id	A41C
biospecimen__bio__plate_row	D
biospecimen__bio__quantity	2.21
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	13.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-DD-AACN
biospecimen__shared__patient_id	AACN
clinical__ablation__ablation_performed_indicator	NO
clinical__ablation__bcr_ablation_barcode	TCGA-DD-AACN-A66125
clinical__ablation__bcr_ablation_uuid	276C8689-15A0-4900-8451-29E56E7794D9
clinical__ablation__days_to_embolization_performed	379
clinical__ablation__embolization_performed_indicator	YES
clinical__ablation__embolization_therapy_drug_name	Other
clinical__ablation__embolization_therapy_drug_name_other	adriamycin
clinical__ablation__embolization_type	Chemoembolization
clinical__ablation__embolizing_agent_utilized	Other, specify
clinical__ablation__embolizing_agent_utilized_other	lipidol
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	74F5F3D2-D518-499D-BB3A-6FEBD30A60D1
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.8
clinical__chol_lihc_shared__albumin_result_specified_value	3.9
clinical__chol_lihc_shared__albumin_result_upper_limit	5.3
clinical__chol_lihc_shared__bilirubin_lower_limit	0.2
clinical__chol_lihc_shared__bilirubin_upper_limit	2.2
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.7
clinical__chol_lihc_shared__creatinine_upper_limit	1.5
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.5
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	9
clinical__chol_lihc_shared__fetoprotein_outcome_value	699
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis B
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	1.0
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.0
clinical__chol_lihc_shared__platelet_result_lower_limit	130
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	1.0
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Multiple
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.2
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	32
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-AACN-F68372
clinical__clin_shared__bcr_followup_uuid	856E9DD8-A3A9-4A61-B8F2-69D29BB8ECA5
clinical__clin_shared__day_of_form_completion	2
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	6
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	185
clinical__clin_shared__post_op_ablation_embolization_tx	YES
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2009
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	Yes
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	NO
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	357
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Intrahepatic Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G3
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	d3633d63-7cbe-4014-b051-211240a29ac8
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-AACN-01A-11R-A41C-07
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	c24a8aaa-0350-4224-9c50-713a5d681654,6ea92963-cbfb-498d-b6af-172ebfb440f5,b7a4f040-dd28-4417-9461-cd2e66365fca
gdc__analysis__workflow_link	https://github.com/NCI-GDC/htseq-cwl
gdc__analysis__workflow_type	HTSeq - Counts,HTSeq - FPKM-UQ,HTSeq - FPKM
gdc__analysis__workflow_version	v1
gdc__analytes__a260_a280_ratio	1.87
gdc__analytes__analyte_id	c3b147c1-e059-42a5-ba90-3402147b45ea
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	0afd4283-7311-4d69-a2f5-779628da45fc
gdc__center__center_id	ee7a85b3-8177-5d60-a10c-51180eb9009c
gdc__center__center_type	CGCC
gdc__center__code	07
gdc__center__name	University of North Carolina
gdc__center__namespace	unc.edu
gdc__center__short_name	UNC
gdc__created_datetime	2016-05-26T21:10:31.583178-05:00,2016-05-26T21:10:31.782948-05:00,2016-05-26T21:10:31.953426-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	Gene Expression Quantification
gdc__demographic__demographic_id	f1d82c1b-24ac-5d83-abbf-0d45a0878557
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	asian
gdc__demographic__year_of_birth	1977
gdc__diagnoses__age_at_diagnosis	12007
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-12007.0
gdc__diagnoses__days_to_last_follow_up	1302.0
gdc__diagnoses__diagnosis_id	77bcde49-705c-596a-9568-51d2051be197
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	RNA-Seq
gdc__exposures__bmi	23.93898977463151
gdc__exposures__exposure_id	9180bc9c-2849-567b-bb4c-e3930387670c
gdc__exposures__height	171.0
gdc__exposures__weight	70.0
gdc__file_id	db919923-c86a-4e4c-bff1-484a80b9a19b,af950822-f153-49b2-b8aa-4114238b65a5,551cfea5-c4e7-47cb-ac10-ad2aea7e4fda
gdc__file_name	2332d0de-9bc6-44e0-b1d4-03fb037b2568.htseq.counts.gz,2332d0de-9bc6-44e0-b1d4-03fb037b2568.FPKM-UQ.txt.gz,2332d0de-9bc6-44e0-b1d4-03fb037b2568.FPKM.txt.gz
gdc__file_size	247510,498734,496767
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	RNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	47ff763650650f0adbb1ce3b0f85242c,596083f1817f9575572903bd33114408,f6c266441cb6836b9f8d32a6fbbe0bf4
gdc__portions__is_ffpe	false
gdc__portions__portion_id	33ad5e16-2485-4d5a-a1f1-06f811bf0e23
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	1644
gdc__samples__initial_weight	40.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	449B3C67-3530-4728-9F38-F44F4D8EC027
gdc__samples__sample_id	a118a851-65b2-4604-8b33-b731410cc205
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	4.0
gdc__slides__percent_monocyte_infiltration	1.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	1.0
gdc__slides__percent_normal_cells	15.0
gdc__slides__percent_stromal_cells	15.0
gdc__slides__percent_tumor_cells	70.0
gdc__slides__percent_tumor_nuclei	70.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	0a5e846f-e723-4496-8ecc-c7cbe4dd58dc
gdc__submitter_id	2332d0de-9bc6-44e0-b1d4-03fb037b2568_count,2332d0de-9bc6-44e0-b1d4-03fb037b2568_uqfpkm,2332d0de-9bc6-44e0-b1d4-03fb037b2568_fpkm
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	3c6b1028-4ccb-5fd2-a79f-ae71f07087a0
gdc__type	gene_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T08:11:01.697+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/d3633d63-7cbe-4014-b051-211240a29ac8-geq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/d3633d63-7cbe-4014-b051-211240a29ac8-geq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	5069695
manually_curated__local_md5	10c2dcfd5a03cd231cee451c68252645
manually_curated__opengdc_download_date	2018-10-15T16:23:08.000785+02:00
manually_curated__opengdc_file_md5	a95b2b7786bec699cdf16c9807120782
manually_curated__opengdc_file_size	1259463
manually_curated__opengdc_id	d3633d63-7cbe-4014-b051-211240a29ac8-geq
manually_curated__origin_file_size	5069695
manually_curated__origin_last_modified_date	Mon Oct 15 16:39:00 CEST 2018
manually_curated__origin_md5	10c2dcfd5a03cd231cee451c68252645
manually_curated__tissue_status	tumoral
num	60483
